Lupin Limited — Board Meeting, 12-02-2025: Outcome of Board Meeting

The Board of Directors of Lupin Limited has approved significant strategic initiatives, including the reappointment of Ms. Vinita Gupta as CEO for an additional five years beginning May 28, 2025, and Mr. Ramesh Swaminathan as Executive Director and CFO for another five years starting March 26, 2025. The company will also transfer its Over-the-Counter Consumer Healthcare Business to a newly incorporated wholly owned subsidiary, LUPINLIFE Consumer Healthcare Limited, with expected consideration ranging from ₹550 crore to ₹650 crore. Additionally, Lupin will implement an Employee Stock Option Scheme 2025, allowing for the grant of up to 10 million options to eligible employees.